An amiloride derivative is active against the F1Fo-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An amiloride derivative is active against the F1Fo-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis
Authors
Keywords
-
Journal
Communications Biology
Volume 5, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-24
DOI
10.1038/s42003-022-03110-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The cryo-EM structure of the bd oxidase from M. tuberculosis reveals a unique structural framework and enables rational drug design to combat TB
- (2021) Schara Safarian et al. Nature Communications
- Dual inhibition of the terminal oxidases eradicates antibiotic‐tolerant Mycobacterium tuberculosis
- (2020) Bei Shi Lee et al. EMBO Molecular Medicine
- Structure of mycobacterial ATP synthase bound to the tuberculosis drug bedaquiline
- (2020) Hui Guo et al. NATURE
- Utilization of CRISPR Interference To Validate MmpL3 as a Drug Target in Mycobacterium tuberculosis
- (2019) Matthew B. McNeil et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of M. tuberculosis to bedaquiline
- (2019) Zhe Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 6-Substituted amiloride derivatives as inhibitors of the urokinase-type plasminogen activator for use in metastatic disease
- (2019) Benjamin J. Buckley et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting bacterial energetics to produce new antimicrobials
- (2018) Kiel Hards et al. DRUG RESISTANCE UPDATES
- Ionophoric effects of the antitubercular drug bedaquiline
- (2018) Kiel Hards et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer
- (2018) Benjamin J. Buckley et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pyrazolo[1,5-a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis
- (2018) Xiaoyun Lu et al. ACS Infectious Diseases
- Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis
- (2017) Subramanyam J. Tantry et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploiting the synthetic lethality between terminal respiratory oxidases to killMycobacterium tuberculosisand clear host infection
- (2017) Nitin P. Kalia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Turning the respiratory flexibility of Mycobacterium tuberculosis against itself
- (2016) Dirk A. Lamprecht et al. Nature Communications
- Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis
- (2015) Supriya Singh et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Bactericidal mode of action of bedaquiline
- (2015) K. Hards et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antiinfectives targeting enzymes and the proton motive force
- (2015) Xinxin Feng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure of the mycobacterial ATP synthase Fo rotor ring in complex with the anti-TB drug bedaquiline
- (2015) L. Preiss et al. Science Advances
- Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis
- (2014) R. C. Hartkoorn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- X-Ray Structure of Acid-Sensing Ion Channel 1–Snake Toxin Complex Reveals Open State of a Na+-Selective Channel
- (2014) Isabelle Baconguis et al. CELL
- Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases
- (2014) Kai Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
- (2014) Koen Andries et al. PLoS One
- Enhanced Specialized Transduction Using Recombineering in Mycobacterium tuberculosis
- (2014) J. M. Tufariello et al. mBio
- Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism
- (2014) Anil Koul et al. Nature Communications
- Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis
- (2014) Keertan Dheda et al. Lancet Respiratory Medicine
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- Tuberculosis success
- (2013) Dan Jones NATURE REVIEWS DRUG DISCOVERY
- Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis
- (2013) H. Eoh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Approval of Novel TB Drug Celebrated--With Restraint
- (2013) J. Cohen SCIENCE
- Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
- (2012) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Regulation of proline metabolism in mycobacteria and its role in carbon metabolism under hypoxia
- (2012) Michael Berney et al. MOLECULAR MICROBIOLOGY
- Avogadro: an advanced semantic chemical editor, visualization, and analysis platform
- (2012) Marcus D Hanwell et al. Journal of Cheminformatics
- In vitro differentiation of human macrophages with enhanced antimycobacterial activity
- (2011) Guillaume Vogt et al. JOURNAL OF CLINICAL INVESTIGATION
- Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier
- (2011) Kyu Y. Rhee et al. TRENDS IN MICROBIOLOGY
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis
- (2008) Anil Koul et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started